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Abstract
Geranylgeranyl transferase (GGTase) is an enzyme involved in the prenylation of many proteins,
including Ras proteins. Prenylation is the addition of a hydrophobic hydrocarbon chain to a
molecule. This addition is responsible for the activation of signaling pathways connected to cell
growth and development. A malfunction of prenylated Ras proteins can lead to uncontrollable
cell growth and proliferation which can lead to many types of diseases, including cancer. This
study focuses on the synthesis of a probe that is identical to the GGTase natural substrate,
geranylgeranyldiphosphate (GGPP), with the only difference being the addition of a norbornene
motif. This non-natural GGTase substrate will trick the enzyme into binding with the non-natural
substrate rather than its natural substrate geranylgeranyldiphosphate. The non-natural substrate
can then be used in conjugation with a modified tetrazine molecule for the selective inhibition of
GGTase. Norbornenes have shown promise in bioconjugation reactions with modified tetrazines.
Bioconjugation reactions are reactions which contain desirable features to occur in biological
settings using reactants that are biologically inert. Future directions include in vitro and in vivo
tests of the synthesized probe on the inhibition of GGTase.
Background
Cell signaling describes how cells relay information to one another. This process has three general
steps reception, transduction, and cellular response (Figure 1). Reception describes when a
signaling chemical binds to a receptor protein on the cell membrane. This interaction leads to a
series of relay molecules passing the signal through the signal transduction pathway known as
transduction. Finally, the signal leads to a response.15 Geranylgeranyltransferase (GGTase) plays
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a significant role in regulating cell signaling by causing proteins to become associated with the
cell membrane, consequently activating them for use in regular cell growth and proliferation.
This signaling is done by inducing hydrophobicity on proteins containing a CaaX sequence present
on their C-terminus. A CaaX sequence is representative of a chain of four amino acids in the order
of cysteine, two aliphatic amino acids, and then any amino acid. This increase in hydrophobicity
causes membrane association and subsequent activation of downstream processes.
Geranylgeranyl transferase has shown to have a significant connection to oncogenesis, as well as
other diseases, through the prenylation of proteins that regulate cell growth and replication. The
primary function of GGTase is to attach a “membrane anchor”, or a non-polar geranylgeranyl
group, to proteins in order to make them become membrane associated.1 Further knowledge of
GGTase will prove valuable for possible oncogenesis inhibition.

Figure 1. Cartoon model of cell signaling pathway.15
GGTase is a member of a group of proteins known as prenyltransferases, which are a family of
proteins that primarily induce membrane association of other complexes.6 There are three main
types of prenyltransferases; farnesyltransferase, GGTase, and Rab GGTase. 6 Farnesyltransferase
functions as an enzyme that transfers farnesyl groups to proteins in order to introduce
3

hydrophobicity.6 The natural substrate of farnesyltransferase is farnesyl diphosphate (Figure 2).
GGTase functions as an enzyme that transfers geranylgeranyl groups to introduce
hydrophobicity.6 The natural substrate of GGTase is geranylgeranyldiphosphate (Figure 2).
Farnesyl diphosphate consists of three isoprenoid groups while geranylgeranyl diphosphate
consists of four isoprenoid groups (or two geranyl groups).
Finally, Rab GGTase functions as a protein that transfers geranylgeranyl groups more specifically
to a type of protein known as Rab G protiens.6 Rab GGTases are prevalent in ensuring newly
synthesized G-protein coupled receptors (GPCRs) are expressed on the cell membrane surface
for use in cell signaling.16 Farnesyltransferase and GGTase are both CaaX sequence specific,
meaning they catalyze the activation of proteins with a CaaX box specifically, and serve similar
functions to prenylate proteins to allow for membrane association.6 The CaaX sequence refers to
a sequence of amino acids with a cysteine, aliphatic amino acid, aliphatic amino acid, and then
any amino acid.4

Figure 2. Natural substrates for farnesyltransferase and GGTase.
Research on GGTase is significant as its inhibition could help in reducing oncogenesis.2 If GGTase
is inhibited prenylation is stopped and cell signaling related to growth and division will not occur.
This would be especially useful for resolving the effects of mutagenic Ras which is always stuck
in an activated state that forces tumor growth.3
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Biochemical Composition
The biochemical composition of GGTase is complex. The GGTase protein is a dimer of two
subunits; the alpha subunit and the beta subunit.6 The crescent shaped alpha subunit of GGTase
is made up of alpha helices and is roughly 48 kDa, and the beta subunit of GGTase makes up an
alpha-alpha barrel.6 GGTase has been tentatively designated as a metalloenzyme as the presence
of Zn2+ could act as a catalyst for prenylation.5 However, the removal of Zn2+ did not show
evidence for the irreversible inactivation of GGTase.5 It is thought that the zinc cation could be
involved in the coordination of the -SH (thiol) group on the cysteine of the CaaX box with
geranylgeranyl groups (Figure 3).5 Magnesium (II) has also been found within the GGTase enzyme
and is likely involved catalytically in the coordination of geranylgeranyldiphosphate substrates. 5
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Figure 3. Structure of GGTase I with the alpha subunit (red), beta subunit (blue), and catalytic zinc
ion (magenta). The GGTase natural substrate GGPP is shown in cyan. 8
Mechanism
GGTase prenylation of a CaaX-protein using a GGPP substrate forms a prenylated protein and a
diphosphate byproduct.4 The active site of GGTase is located within the funnel shaped cavity of
the alpha-alpha barrel of the beta subunit (Figure 3).6 The inside of this alpha-alpha barrel is
hydrophobic and rich in aromaticity.6 The hydrophobicity of the beta subunit attracts the
geranylgeranyldiphosphate substrate and is stabilized by electrostatic interactions within the
active site.6 The zinc (II) ion that is responsible for catalyzing the reaction is coordinated to the
beta subunit residues Aspb269, Cysb271, and Hisb321.6 Specificity of both GGTase and protein
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farnesyltransferase could be due to the presence of Thrb49, Pheb53, and Pheb324 within the
active site in GGTase, these residues can accommodate the extra fourth isoprenoid group present
on geranylgeranyldiphosphate (Figure 4).6

Figure 4. Crystal structures of GGTase and farnesyltransferase depicting zinc ion coordination and
residues present in the active sites. Pink residues are of GGTase with the GGPP substrate in cyan.
Green residues are of farnesyltransferase with FPP substrate in magenta. 6

There are three main steps to the GGTase mechanism; prenylation, proteolysis, and carboxyl
methylation (Figure 5).6 Prenylation refers to the addition of a geranylgeranyl group to the Cterminal of CaaX-proteins, specifically to the -SH (thiol) group of the cysteine present in the CaaX
box.4 The CaaX sequence consists of a cysteine, two alliphatic amino acids, and any amino acid
for the “X” variable, often of which for GGTase is leucine.14 Then, the formed CaaX proteinisoprenoid complex becomes attached to the endoplasmic reticulum.6 The next stage of this
process, proteolysis, refers to the cleavage of the AAX amino acids from the aforementioned
CaaX box by use of an enzyme known as the Ras converting enzyme (RCE1).6 Finally, in the
7

carboxyl methylation stage of the mechanism, the resulting terminal cysteine becomes
methylated by a protein known as isoprenylcysteine methyltransferase (Icmt). At this point the
protein is hydrophobic enough to become associated with the cell membrane but, in some cases,
the

association is

relatively

unstable. This

instability

leads

to another

enzyme

palmitoyltransferase, which is responsible for a lipid modification to the protein known as
palmitoylation, to take over.18 Palmitoylation is the addition of a hydrophobic functionality to
the residual cysteine from the aforementioned CaaX box in the form of palmitate (Figure 6).19
The addition of the additional hydrophobic chain can allow for a more stable association of
activated proteins with the cell membrane.

Figure 5. Graphic demonstrating GGPP substrate and a protein with a CaaX motif undergoing the
three steps needed for membrane assosiation.9
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Figure 6. Graphic demonstrating movement of a Ras protein moving through the cell as it is
prenylated.18
GGTase Inhibition
An important feature of any enzyme or protein is how the protein is regulated. GGTase regulates
Ras proteins by allowing them to become membrane associated.6 Naturally, a desire for synthetic
GGTase inhibitors arises to prevent the out of control cell growth and division that arises with
Ras protein mutation. GGTase inhibitor GGTI-2418 has been synthesized to inhibit GGTase
selectively and has entered clinical trials, but with severe side effects. 6 GGTI-2418 works as a
competitive inhibitor with the geranylgeranyldiphosphate substrate for GGTase (Figure 7).6
Another GGTase inhibitor that has been looked into is GGTI-2154 which has shown to induce
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breast cancer cell death and tumor regression in H-Ras transgenic mice.6 GGTI-2514 also works
as a competitive inhibitor with the protein substrate geranylgeranyldiphosphate (Figure 7).6 Both
of these inhibitors were designed to have a similar structure to a CaaX box motif that might be
recognized by GGTase in the form of CVIL (Figure 7). In that way, these molecules would inhibit
GGTase by occupying the enzyme’s active space which would not allow for further activation of
other proteins. However, the use of inhibitors that effect the ability of prenyltransferases to
function can lead to decreased activation of other common proteins required for regular cell
growth and proliferation.17

Figure 7. Line structures of potential GGTase inhibitors GGTI-2418 and GGTI-2154 in comparison
to the CVIL CaaX box motif of GGTase recognized proteins.17
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Application and System
Prenyltransferase enzymes are an important area of investigation due to the dramatic effect their
inhibition could have on cancer cell development. Mutations to the Ras oncogene can induce
irreversible activation of Ras proteins causing uncontrollable cell division and growth which is
incredibly significant as roughly 20% of tumors are induced by these Ras mutations.3 N-Ras, HRas, and K-Ras are all examples of Ras protein substrates for prenyltransferases enzymes. 6
However, these Ras proteins are more commonly prenylated by another type of
prenyltransferase known as protein farnesyltransferase.6 Consequently, in the case of Ras
protein mutation leading to uncontrollable cell growth and division, one’s first instinct would be
to inhibit the protein farnesyltransferase in order to prevent further uncontrollable cell growth.
This method has been noted to work well in the case of H-Ras protein mutations, however with
the inhibition of farnesyltransferase N-Ras and K-Ras can go on to be prenylated by GGTase.6
Therefore, a combination of protein farnesyltransferase inhibitor and GGTase inhibitor is needed
for the total inhibition of Ras protein prenylation. 6
Further study on these prenyltransferases enzymes can also lead to new information on a disease
known as Progeria. Progeria is a disease that leads to rapid aging and early death and it occurs
when a point mutation to the LMNA gene leads to the replacement of a cytosine to a thiamine. 6
This point mutation changes the gene to encode for a progerin protein rather than the norm. 6
The progerin protein is a CaaX protein which allows for it to become prenylated by one of the
prenyltransferases once the prenylated progeria protein become associated to membranes a
Progeria phenotype results.6
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Results/Discussion:

Figure 8. Proposed six step reaction scheme for the synthesis of a nor-O-C15-OPP non-natural
GGTase substrate. Dotted arrows indicate reaction was not yet completed.
A six-step synthesis of the desired norbornene containing substrate (1-6) was proposed. Three of
the six proposed reactions were successfully carried out to yield (1-3) as a fully characterized
intermediate (Figure 8).
(1-6) is a Possible GGTase Substrate Which Could Allow for Further Enzyme Study
The natural substrate of GGTase, geranylgeranyldiphosphate (GGPP), has an isoprenoid
containing structure that is 20 carbons long with a diphosphate functionality along it’s terminus.
The proposed substrate (1-6) is similar in length and size to the natural substrate GGPP, however
(1-6) has norbornene motif which can be utilized for its reactivity (Figure 9).
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Figure 9. Line structures depicting the similarities between the natural GGTase substrate, GGPP,
and the synthesized probe, Nor-O-C15-OPP. Both compounds are similar in shape and size as well
as take up similar amounts of space.

(1-6) Shows Promise for Bioconjugation with Tetrazine in Biological Systems
A bioconjugation reaction defines a biologically inert and selective reaction that allows for the
further study of target proteins and peptides.7 Bioconjugation reactions are typically two-step
reactions. First, a biomolecule is modified with a biologically inert motif capable of selectively
reacting with a different biologically inert motif. Next, a reaction is then completed between the
two motifs . The second motif is designed to have the capability of holding a cargo (Figure 10).7
The cargo would then be specifically targeted to cells and enzymes of interest rather than being
administered to undesired cells. These reactions have been useful in protein engineering,
immunoassay development, cell surface modification, and biolabeling.7 The cargo delivered to
the target of interest could include fluorescent markers for visualization, or even therapeutics.

The motif utilized in this study is a norbornene for bioconjugation reaction with tetrazine. This
was chosen for its cost, stability, and commercial availability. Tetrazines have shown to complete
ligation with other motifs in a bioconjugation reactions. One study shows the significance of non-
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strained alkene-tetrazine cycloaddition to form what is known as a triazoline (Figure 11).11 These
reactions were promoted by ring strain or light and have been known to be unstable in
comparison to other cycloaddition reactions.11 The lower stability of triazolines makes them less
desirable of a bioconjugation reaction as they are likely to be more reactive with other species.
The oxanorbornadiene has also shown promise in ligation reactions with tetrazine in which it
undergoes a [3+2] Diels Alder cycloaddition (Figure 11).12 This type of reaction, however, yielded
rather slow reaction rates at approximately 10-4 M-1s-1.11 The tetrazine ligation with strained
alkenes however have shown a faster reaction rate (Figure 11). For example, the strained alkene
trans-cyclooctene reacted with a modified tetrazine with a second order rate constant of roughly
103 M-1s-1, this is ten million times faster.13
Norbornenes have been shown to react well with tetrazines due to their balance between strain
promoted reactivity and their chemical stability.7 Due to these capabilities it is hypothesized that
the synthesized substrate (1-6) will successfully perform a bioconjugation reaction with tetrazine
in a biological environment. Tetrazine molecules containing attached cargo can be specifically
delivered to (1-6) when reacted. This capability could allow for the specific delivery of identifiers,
treatments, or other cargos to the GGTase enzyme.
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Figure 10. Visual representation of biorthogonal reactions. The “warhead” shape is
representative of the target enzyme substrate with an attached biologically inert motif.
Bioconjugation occurs with the addition of the chemical labeling reagent with the star shape
being representative of the cargo being delivered to the target enzyme. 11
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(a)

(b)

(c)

Figure 11. Triazoline synthesis by non-strained alkene-tetrazine cycloaddition route (a),
oxanorbornadiene-tetrazine ligation (b), tetrazine ligation with strained norbornene alkene (c).13
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Nor-C15-O-THP Synthetic Route
The first step of the proposed 6 step synthetic route was used to protect the terminal alcohol
present on the geraniol starting material. Protection of the terminal alcohol was accomplished
through the use of a THP group. Oxidation of the protected product (1-1) led to the synthesis of
many undesired isomers, along with the desired isomer (1-2) (figure 12). This 2,3-sigmatropic
rearrangement led to the addition of hydroxyl or aldehyde groups at each methyl group present
on the starting material. There was no way to avoid this but some of the potential side products
could be reduced through careful reaction monitoring. Purification of the desired isomer (1-2)
was obtained through column chromatography. The intent of this oxidation reaction was to
induce more reactivity to the terminal end of the compound for subsequent modifications.

Figure 12. Depiction of possible isomers that could have been synthesized during oxidation
reaction for the desired (1-2). The desired product in green, a precursor to the desired product
in orange, and unintended isomers in red.10
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Subsequent bromination following the oxidation was to promote a single replacement
mechanism between the terminal bromine and norbornene functional groups in following
steps. Two synthetic routes were attempted for the bromination leading to the synthesis of (13). The first route included the use of dry ice to cool the N-bromosuccinimide-dimethylsulfide
solution to temperatures much lower than 0oC for up to an hour before being warmed and recooled. This method also required a much longer reaction time at roughly an hour after the
addition of (1-2). The second route for the synthesis of (1-3) was as described in the methods
section where the N-bromosuccinimide-dimethylsulfide was cooled to a temperature of 0oC by
use of ice and reaction times were significantly shorter at roughly ten minutes after the
addition of HO-C15-OTHP. The second reaction was favored as higher percent yields were
achieved, as well as it proved to be a greener synthetic method.
Characterization of brominated compound (1-3) via 1H-NMR yielded an unexpected splitting
pattern for the peak at 4.4 ppm (Figure 13). This peak is expected to be representative of the
CH2 group adjacent to the bromine on (1-3) which should appear as having the splitting pattern
of a singlet. A possible explanation for the unexpected result could be the presence of a regioisomer of the compound where the bromine is present on the methyl group adjacent to its
desired place (Figure 14). Further analysis is necessary for a more cohesive explanation.
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Figure 13. 1H-NMR spectra for (1-3) with the unexpected splitting pattern for 𝛼 at 4.4 ppm
shown by the orange arrow.

Figure 14. Suggested line structures of the possible regio isomer of brominated intermediate (13) (right) compared to the desired terminal bromide isomer of (1-3) (left).

Synthesis of (1-4) included the addition of a norbornene motif. Characterization of (1-4) via 1HNMR showed the product synthesized, while it did show signs of the desired product (1-4), was
impure and not viable for further use in the procedure.
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Conclusions:
GGTase has been shown to activate mutated proteins, such as Ras proteins, leading to
oncogenesis. Through the proposed 6-step synthesis, (1-6) shows promise for the identification
and inactivation of GGTase enzymes by synthesizing a non-natural substrate capable of
biocojugation. Three of the six steps were successfully carried out and characterized. Further
work for the optimization and completion of the synthesis of the desired product (1-6) is needed.
After completion of the synthesis, a series of in-vitro and in-vivo tests on the capabilities of this
molecule to carry out successful bioconjugation reactions with a modified tetrazine will be
completed.
Experimental and Methods:
C15-O-THP (1-1)
All trans farnesol (15 g, 67.45 mmol), DHP (9.11 ml, 99.83 mmol), and PPTs (1.275 g, 5.059 mmol)
was combined in dichloromethane (DCM) (100 ml) and stirred at room temperature for 5 hours.
Reaction progress was monitored by TLC. The reaction mixture was concentrated, diluted with
ether (30 ml), and washed with brine (3x30 ml). The ether layer was dried with sodium sulfate
and concentrated to yield 17.468 g C15-O-THP (84.6% yield).
HO-C15-O-THP (1-2)
C15-O-THP (10 g, 32.629 mmol), t-BuOOH (4.352 g, 48.291 mmol), SeO2 (0.1195 g, 1.077 mmol),
and salicylic acid (0.1488 g, 1.077 mmol) were dissolved in DCM (20 ml) stirred overnight.
Reaction progress was monitored by TLC. The reaction mixture was concentrated, and excess tBuOOH was removed by diluting the reaction mixture with toluene (25 ml) and concentrating it
off. Then, the mixture was diluted with toluene (50 ml) and washed with water (3x80ml) before
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concentrating off the toluene from the organic layer. Then, the mixture was diluted with ether
(80 ml) and washed with NaHCO3 (100 ml) before drying the organic layer with Na2SO4. The
resulting solution was purified with column chromatography in (7:3 hexane:EtoAc) to yield 1.115
g HO-C15-O-THP (11.15% yield).
Br-C15-O-THP (1-3)
N-bromosuccinimide (NBS) (0.703 g, 3.950 mmol) was dissolved in dichloromethane (DCM) (5 ml)
cooled to below -10oC, and put under N2. Next, dimethylsulfide (DMS) (0.315 g, 5.077 mmol) was
added and the reaction mixture was stirred for 1 hour. Then the mixture was warmed to 0 oC and
re-cooled to below -10oC. HO-C15-O-THP (1g, 3.103 mmol) was dissolved in DCM (5 ml) and
stirred for 20 minutes before addition to the reaction solution. Reaction progress was monitored
through TLC in 3:4 hexane:EtOAc. The reaction was quenched using saturated NaHCO3 (10 ml),
extracted with EtoAc (3x20 ml), and dried using MgSO4. Residual EtoAc was concentrated off and
the mixture was purified using column chromatography in (3:4 hexane:EtOAc) to yield 0.136
grams of Br-C15-O-THP (11.4% yield).
Nor-C15-O-THP (1-4)
Norbornene alcohol (0.0383 g, 3.098 x 10-4 mmol) was dissolved in THF (1 mL) at 0OC in a pressure
tube. Next, 30% NaH dispersion in mineral oil (0.0125 g, 5.21 x 10-4 mmol) was added and the
solution stirred for 10 minutes to form a white liquid. Brominated isoprenoid (1-3) (0.10 g,
0.00026 mmol) was added to the solution which subsequently caused the solution to turn a dark
yellow-orange color. The solution was stirred for 1 week. Reaction progress was monitored
through TLC conditions. Then, the reaction was quenched with water (20 mL) and washed with
EtOAc (3x20mL). The product was dried with NaSO4 and concentrated. Residual EtOAc was
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concentrated off and the mixture was purified using column chromatography (95:5
hexane:EtoAc) to yield an impure product.
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Spectra Appendix:
(1-1): C15-O-THP
1H-NMR

(400 MHz, CDCl3)
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(1-2): HO-C15-O-THP
1H-NMR

(400 MHz, CDCl3)

M, N, O

B, F

J
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(1-3): Br-C15-O-THP
1H-NMR (400 MHz, CDCl )
3

M, N, O

DCM Impurity
B
F
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